Glioblastoma Multiforme (GBM) Treatment Market Report 2023- Size, Trends, Growth, Drivers, And Forecast To 2032 | Merck & Co Inc., F. Hoffmann-La Roche AG, Amgen Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd.

Glioblastoma Multiforme (GBM) Treatment Market
Spread the love

The Business Research Company’s Glioblastoma Multiforme (GBM) Treatment Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Glioblastoma Multiforme (GBM) Treatment Global Market Report 2023 evaluates glioblastoma multiforme (GBM) treatment market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=8803&type=smp

The global glioblastoma multiforme (GBM) treatment market is expected to grow from $2.04 billion in 2022 to $2.26 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The glioblastoma multiforme (GBM) treatment market is expected to grow to $3.26 billion in 2027 at a CAGR of 9.7%.

The glioblastoma multiforme (GBM) treatment market segments in the report are:

By Treatment:
Surgery
Radiation Therapy
Chemotherapy
Targeted Therapy
Tumor Treating Field (TTF) Therapy
Immunotherapy

By Drug Class:
Temozolomide
Bevacizumab
Lomustine
Carmustine Wafers
Other Drug Classes

By Route of Administration:
Oral
Parenteral
Other Route Of Administrations

By End-Use:
Hospitals
Clinics
Ambulatory Surgical Centers

Top Major Players:

North America was the largest region in the glioblastoma multiforme (GBM) treatment market in 2022.

Get More Information On The Glioblastoma Multiforme (GBM) Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/glioblastoma-multiforme-GBM-treatment-global-market-report

The table of contents in TBRC’s glioblastoma multiforme (GBM) treatment market report includes:

1. Executive Summary
2. Glioblastoma Multiforme (GBM) Treatment Market Characteristics
3. Glioblastoma Multiforme (GBM) Treatment Market Trends And Strategies
4. Glioblastoma Multiforme (GBM) Treatment Market – Macro Economic Scenario
5. Glioblastoma Multiforme (GBM) Treatment Market Size And Growth
………
26. Africa Glioblastoma Multiforme (GBM) Treatment Market
27. Glioblastoma Multiforme (GBM) Treatment Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Glioblastoma Multiforme (GBM) Treatment Market
29. Glioblastoma Multiforme (GBM) Treatment Market Future Outlook and Potential Analysis
30. Appendix

List Of Tables

Table 1: Global Historic Market Growth, 2017-2022, $ Billion

Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion

Table 3: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

Table 4: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

Table 5: Global Glioblastoma Multiforme (GBM) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

……

Table 47: Merck & Co Inc. Financial Performance

Table 48: F. Hoffmann-La Roche AG Financial Performance

Table 49: Amgen Inc. Financial Performance

Table 50: Pfizer Inc. Financial Performance

Table 51: Teva Pharmaceutical Industries Ltd. Financial Performance

Read Related Reports:

Neurology Devices Global Market Report 2023
Neurodegenerative Disorder Therapeutics Global Market Report 2023
Neurophysiology Devices And Equipment Global Market Report 2023

Learn About Us: 

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us: 
The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company 

Twitter: https://twitter.com/tbrc_info 

Facebook: https://www.facebook.com/TheBusinessResearchCompany 

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ 

Blog: https://blog.tbrc.info/ 

Healthcare Blog: https://healthcareresearchreports.com/ 

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model 


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →